• Policy & Insight

Opinion: 'Let’s not be short-sighted – the UK’s medical research charities need urgent support'

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding. Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

24 September 2020

• Science & Technology

The team of over 60 scientists investigating the age-old mystery of inflammation and cancer

We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer. We spoke to 3 members of the global STORMing Cancer team about their work to solve the mystery of inflammation and cancer.

24 September 2020

• Science & Technology

Children and young people with cancer who have relapsed can get rapid access to new treatments, thanks to new Cancer Research UK trial

Children and young people in the UK with cancers that have come back can now access new personalised treatments quicker than ever before. Children and young people in the UK with cancers that have come back can now access new personalised treatments quicker than ever before.

4 September 2020

• Science & Technology

Cancer Research UK and AstraZeneca’s new antibody maturation technique yields high-affinity Arginase 2 antibody

Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2. Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.

3 September 2020

• Health & Medicine

The changing landscape of children's cancer treatment

We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored. We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children's cancer treatment more tailored.

2 September 2020

• Science & Technology

Teaching evolutionary theory to artificial intelligence reveals cancer’s life history

Scientists have developed the most accurate computing method to date to reconstruct the patchwork of genetic faults within tumours and their history. Scientists have developed the most accurate computing method to date to reconstruct the patchwork of genetic faults within tumours and their history.

2 September 2020

• Charity News
• Science & Technology

Transatlantic scientific partnership to connect world researchers in quest to solve cancer’s toughest problems

Cancer Research UK and the US National Cancer Institute, are uniting to define a new era in cancer research and discovery. Cancer Research UK and the US National Cancer Institute, are uniting to define a new era in cancer research and discovery.

27 August 2020

• Health & Medicine

The team tackling the serious side effects of cancer treatment in an ageing population

We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer. We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.

19 August 2020

• Health & Medicine

Are differences in treatment driving variation in ovarian cancer survival internationally?

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go. The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

11 August 2020

• Health & Medicine

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

15 July 2020

• Health & Medicine
• Science & Technology

COVID-19: “It could take months to build research up again”

Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre. Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre.

1 July 2020

• Science & Technology

Secrets of naked mole-rat cancer resistance unearthed

Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research. Naked mole-rats' exceptional resistance to cancer is thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research.

1 July 2020